As of Apr 21
| -0.0959 / -4.17%|
The 1 analysts offering 12-month price forecasts for CounterPath Corp have a median target of 3.35, with a high estimate of 3.35 and a low estimate of 3.35. The median estimate represents a +51.85% increase from the last price of 2.20.
The current consensus among 1 polled investment analysts is to Outperform stock in CounterPath Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.